Upper airway surgery: the effect on nasal continuous positive airway pressure titration on obstructive sleep apnea patients

The objective of this study was to observe the change in CPAP pressure after nasal and/or tonsil surgery in a retrospective study involving 17 patients unable to tolerate CPAP titration. All patients had two polysomnography studies for titration: one before and another subsequent to upper airway surgical treatment. the results showed a mean age of 49 +/- 9 years, a body mass index of 30 +/- 4 kg/m(2) and an apnea-hypopnea index of 38 +/- 19. Surgical procedures were radiofrequency reduction of the inferior turbinate (eight patients), septoplasty (one patient), septoplasty with inferior turbinectomy (two patients), septoplasty with inferior turbinate submucosal diathermy (two patients), septoplasty with tonsillectomy (two patients), septoplasty with inferior turbinate submucosal diathermy and tonsillectomy (one patient) and tonsillectomy (one patient). CPAP titration before and after surgery had respectively a mean pressure of 12.4 +/- 2.5 and 10.2 +/- 2.2 cmH(2)O (P = 0.001). Maximum CPAP pressure was 16.4 cmH(2)O before and 13 cmH(2)O after surgery. A pressure reduction >= 1 cmH(2)O occurred in 76.5% of the patients and >= 3 cmH(2)O in 41.1%. Upper airway surgical treatment appears to have some benefit by reducing nasal CPAP pressure levels. the effect seems to be greater when the prior pressure was >= 14 cmH(2)O.Universidade Federal de São Paulo, Dept Psychobiol, Sleep Inst, São Paulo, BrazilUniversidade Federal de São Paulo, Dept Otorhinolaryngol, São Paulo, BrazilUniversidade Federal de São Paulo, Dept Psychobiol, Sleep Inst, São Paulo, BrazilUniversidade Federal de São Paulo, Dept Otorhinolaryngol, São Paulo, BrazilWeb of Scienc

Consenso brasileiro de ronco e apneia do sono: aspectos de interesse aos ortodontistas Brazilian consensus of snoring and sleep apnea: aspects of interest for orthodontists

O objetivo deste artigo é explicitar o posicionamento das sociedades médicas que, reunidas, estabeleceram consenso sobre os parâmetros clínico-laboratoriais que envolvem os distúrbios respiratórios do sono, em especial o ronco e a síndrome da apneia obstrutiva do sono (SAOS). Os ortodontistas, que vêm ocupando gradativamente seu espaço em equipes multidisciplinares que atuam na área do sono humano, pouco conhecem sobre essa uniformização coordenada pela Associação Brasileira de Sono. Os trabalhos clínicos e as pesquisas científicas oriundos da Odontologia, e em particular da Ortodontia, também devem observar e seguir esses critérios de diagnóstico e tratamento estabelecidos pela comunidade médica brasileira.<br>The objective of this article is to clarify the positions of the medical societies that have worked together to establish a consensus regarding the clinical and laboratory parameters involved in sleep-disordered breathing, particularly snoring and obstructive sleep apnea syndrome (OSAS). Orthodontists have gradually come to take part in multidisciplinary teams that act in the area of human sleep, but few know about the uniformity coordinated by the Brazilian Association of Sleep. Clinical and scientific studies from the field of dentistry (particularly orthodontics) also must observe and follow these diagnosis and treatment criteria established by the Brazilian medical community

Avaliação clínica e polissonográfica do aparelho BRD no tratamento da Síndrome da Apneia Obstrutiva do Sono Clinical and polysomnographic assessment of Obstructive Sleep Apnea Syndrome treatment with BRD appliance

OBJETIVOS: este trabalho de pesquisa teve o intuito de realizar uma avaliação clínica e polissonográfica do efeito de um aparelho intraoral (AIO) para tratamento da Síndrome da Apneia Obstrutiva do Sono (SAOS), desenvolvido e testado por duas universidades federais brasileiras. MÉTODOS: a amostra constou de 50 pacientes (idades entre 18 e 65 anos, sendo 33 homens e 17 mulheres) com diagnóstico polissonográfico inicial de SAOS de grau leve e moderado. Todos os pacientes submeteram-se a uma nova avaliação polissonográfica de noite inteira (em uso do AIO) aproximadamente 6 meses após a primeira avaliação. Baseado na diminuição dos eventos respiratórios obstrutivos, obtida com o uso do AIO, os pacientes foram então divididos em bons respondedores (redução de 50% ou mais no índice de apneia e hipopneia (IAH), permanecendo abaixo de 10 eventos/hora) e maus respondedores (IAH permanecendo maior ou igual a 10 eventos/hora). RESULTADOS E CONCLUSÕES: em 54% da amostra o IAH diminuiu para menos de cinco eventos/hora com o uso do AIO; em 38% a redução do IAH foi maior do que 50%, mas permaneceu acima de cinco eventos/hora; e em 6% da amostra o IAH reduziu menos que 50%. Os bons respondedores corresponderam a 86% da amostra estudada, enquanto os maus respondedores a 14%. Houve melhora significativa na escala de sonolência, no IAH, nos microdespertares e na saturação mínima de oxihemoglobina com a terapia utilizada. O Índice de Massa Corpórea elevado parece interferir desfavoravelmente no desempenho do aparelho em estudo.<br>OBJECTIVES: The current investigation aimed to carry out a clinical and polysomnographic assessment of treatment of Obstructive Sleep Apnea Syndrome (OSAS) with an oral appliance (OA) developed and tested by two Brazilian federal universities. METHODOLOGY: The sample was composed of 50 patients (aged between 18 and 65 years, 33 men and 17 women) with initial polysomnographic diagnosis of light to moderate OSAS. All patients underwent a second, full-night polysomnography with the use of the OA approximately 6 months after the first assessment. Based on the reduction of respiratory events obtained with the OA, patients were distributed in good responders (Apnea and Hypopnea Index/AHI under 10 and with reduction of at least 50% in relation to baseline); and poor responders (AHI of 10 or over with OA). RESULTS AND CONCLUSION: In 54% of the sample, AIH reduced to less than five events/hour with OA; in 38% the AHI reduction was more than 50% in relation to baseline (but more than five); and in 6% of the sample, the AHI reduced less than 50%. Good responders corresponded to 86% of the studied sample, while poor responders to 14%. We noticed significant improvement in somnolence, in AIH, in microarousals and also in minimum oxygen saturation with the treatment. Increased body mass index (BMI) seemed to interfere unfavorably in the performance of the OA studied